Transdermal Basal Insulin Patch Study in Type 1 Diabetes

Completed · Phase 1/Phase 2

Conditions studied: Type 1 Diabetes

In brief

This study is designed to evaluate the pharmacokinetics/pharmacodynamics of an investigational basal insulin patch in type 1 diabetes patients.

Key facts

Study ID

NCT00519623

Run by

Altea Therapeutics

People needed

9

Starts

2007-08-01

Expected to finish

2007-12-01

Last updated by the study team

2010-12-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Duration of type 1 diabetes greater than or equal to 10 years
• HbA1c less than or equal to 9.0%
• C-peptide negative
• Ages 18 - 65, male or female
• BMI 18.5 - 32
• Non- smoker
• No advance diabetes complications
• Not pregnant or breast feeding

You may not qualify if…

• Arm or leg rashes, open wounds, or skin conditions
• Psychiatric disorders
• Participation in a clinical research trial in last 3 months
• Clinically significant acute illness

Where it is running

• Altea Therapeutics Clinical Research Center — 387 Technology Circle, NW, Suite 100, Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.